Immunization, measles second dose in Lithuania
Lithuania: Immunization, measles second dose was 85.0% in 2024. ▼ Falling
Immunization, measles second dose in Lithuania, 2000–2024
Source: WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/). Measured in % of children by the nationally recommended age.
Analysis
The most recent figure for immunization, measles second dose in Lithuania is 85.0%, measured in 2024. That is the lowest value across all 25 years on record.
The figure is down 1.2% on the previous year and down 7.6% over ten years.
Over the whole period, immunization, measles second dose in Lithuania peaked at 97.0% in 2000 and was at its lowest, 85.0%, in 2024.
That places Lithuania 90th out of 178 countries with data for 2024, putting it in the middle of the range.
The long-run direction has been consistently falling across the 25 years of available data.
Immunization, measles second dose in Lithuania, year by year
| Year | % of children by the nationally recommended age | Change |
|---|---|---|
| 2000 | 97.0% | — |
| 2001 | 96.0% | -1.0% |
| 2002 | 95.0% | -1.0% |
| 2003 | 93.0% | -2.1% |
| 2004 | 93.0% | +0.0% |
| 2005 | 95.0% | +2.2% |
| 2006 | 94.0% | -1.1% |
| 2007 | 96.0% | +2.1% |
| 2008 | 96.0% | +0.0% |
| 2009 | 94.0% | -2.1% |
| 2010 | 95.0% | +1.1% |
| 2011 | 94.0% | -1.1% |
| 2012 | 93.0% | -1.1% |
| 2013 | 92.0% | -1.1% |
| 2014 | 92.0% | +0.0% |
| 2015 | 92.0% | +0.0% |
| 2016 | 92.0% | +0.0% |
| 2017 | 92.0% | +0.0% |
| 2018 | 92.0% | +0.0% |
| 2019 | 93.0% | +1.1% |
| 2020 | 91.0% | -2.2% |
| 2021 | 88.0% | -3.3% |
| 2022 | 87.0% | -1.1% |
| 2023 | 86.0% | -1.1% |
| 2024 | 85.0% | -1.2% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 94.9% | 93.0% | 97.0% | 10 |
| 2010s | 92.7% | 92.0% | 95.0% | 10 |
| 2020s | 87.4% | 85.0% | 91.0% | 5 |
Countries ranked near Lithuania
More health data for Lithuania
- Un projection of annual infant deaths, annual growth rate 0 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.4537 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,909 deaths per 1,000 people (2090)
- Number of infants who die before age 1 5 deaths (2100)
- Population ages 30-34, female, annual growth rate -1.22 % change on previous year (2025)
- Population ages 30-34, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 30-34, female, per capita 0.0345 units per person (2025)
- Population ages 30-34, male, annual growth rate -2.05 % change on previous year (2025)
- Population ages 30-34, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 30-34, male, per capita 0.0382 units per person (2025)
Frequently asked questions
- What is immunization, measles second dose in Lithuania?
- Immunization, measles second dose in Lithuania was 85.0% in 2024, according to WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/).
- What is the highest immunization, measles second dose recorded in Lithuania?
- The highest recorded value was 97.0% in 2000.
- What is the lowest immunization, measles second dose recorded in Lithuania?
- The lowest recorded value was 85.0% in 2024.
- How does Lithuania rank for immunization, measles second dose?
- Lithuania ranks 90th out of 178 countries with data for 2024.
- Is immunization, measles second dose rising or falling in Lithuania?
- Over the last ten years it is down 7.6%. The long-run trend across the full record is falling.
- Where does this Lithuania data come from?
- The figures come from WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as part of Immunization, measles second dose (% of children by the nationally recommended age). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Child immunization, measles second dose, measures the percentage of children who received two dose of measles containing vaccine according to nationally recommended schedule through routine immunization services in a given year.